Switch to ADA Accessible Theme
Close Menu
Tennessee Personal Injury Lawyer
Hablamos Español Local 865-500-HURT Toll Free 866-862-4855
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Category Archives: Prescription Drug Litigation

Opioids

Should the Owners of Opioid Manufacturers Face Criminal Charges?

By Fox, Farley, Willis & Burnette |

There are a growing number of lawsuits against the manufacturers and distributors of prescription opioids. These dangerous drug cases focus on the role these companies played in triggering the current opioid addiction crisis here in Tennessee and around the country. And public official in some municipalities want to go a step further and pursue… Read More »

Facebook Twitter LinkedIn
Opioid_pills

New Jersey AG Sues Opioid Manufacturer for Deceiving Consumers

By Fox, Farley, Willis & Burnette |

As the nationwide opioid crisis continues to claim more victims, state law enforcement officials are increasing their efforts to hold negligent pharmaceutical companies accountable. On November 13, New Jersey Attorney General Gurbir S. Grewal filed a lawsuit against Janssen Pharmaceuticals, Inc., the Johnson & Johnson subsidiary responsible for selling a number of popular opioid… Read More »

Facebook Twitter LinkedIn
Adoption2

NEONATAL ABSTINENCE SYNDROME: THE OPIOID CRISIS HITS NEWBORNS WITH DEVASTATING EFFECT

By Fox, Farley, Willis & Burnette |

The prescription opioid epidemic has increasingly been in the news the last several years.  At this point, we all know the burden the increasing rate of opioid addiction has placed on government officials, medical professionals, and thousands of families as they grapple with the effects.  More and more, we are learning that the epidemic… Read More »

Facebook Twitter LinkedIn
ProductDef3

Bayer Loses Early Battle to Keep Essure Lawsuits Out of State Courts

By Fox, Farley, Willis & Burnette |

Pharmaceutical giant Bayer currently faces upwards of 17,000 lawsuits throughout the country over Essure, its “permanent birth control” device which is tied to serious injuries. Although no Essure case has gone to trial as of this writing, Bayer is mounting an aggressive legal defense. In addition to denying that Essure is defective–despite announcing plans… Read More »

Facebook Twitter LinkedIn
Medication

West Virginia Judge Refuses to Toss Pradaxa Lawsuit

By Brad Burnette |

Even when a drug is approved as safe and effective for sale in the United States, manufacturers must still take steps to ensure their products are accurately labeled. This includes disclosing any known potential side effects or contraindications that would make the drug dangerous–even fatal–for certain patients and treatment situations. Unfortunately, far too many… Read More »

Facebook Twitter LinkedIn
Medication2

New York Court Allows Pradaxa-related Malpractice Lawsuit to Proceed

By Brad Burnette |

Defective drug injuries are often difficult to diagnose. After all, most of us do not have advanced medical degrees. We rely on doctors to tell us when there is something wrong and identify the potential causes. And when a doctor’s misdiagnosis or malpractice further compounds the problem, he or she may be liable for… Read More »

Facebook Twitter LinkedIn
Legal_MedMal

Jury Orders C.F. Bard to Pay $3.6 Million in IVC Filter Case

By John Willis |

There are currently thousands of defective medical device lawsuits pending against C.R. Bard, Inc., the New Jersey-based manufacturer of IVC filters. An IVC filter is supposed to “catch” blood clots in the body before they travel up a person’s inferior vena cava and cause a potentially fatal pulmonary embolism. However, many patients have suffered… Read More »

Facebook Twitter LinkedIn
Opioid

FDA Targets Opioid-Containing Dietary Supplements

By John Willis |

As opioid addiction continues to ravage many Tennessee communities, the U.S. Food and Drug Administration (FDA) has taken action against the manufacturers of so-called dietary supplements that contain opioid compounds. More than two years ago, the FDA directed federal marshals to seize over 90,000 bottles of supplements containing kratom, the common name for a… Read More »

Facebook Twitter LinkedIn
GavelBooks

First “Bellwether” Taxotere Trials to Begin in 2018-2019

By John Willis |

One of the most common side effects of chemotherapy is temporary hair loss. Unfortunately, the manufacturers of certain chemotherapy drugs like docetaxel–marketed by Sanofi-Aventis under the brand name Taxotere–failed to disclose their products may actually cause permanent hair loss. In 2015, the U.S. Food and Drug Administration required Sanofi-Aventis to amend its labeling for… Read More »

Facebook Twitter LinkedIn
ProdLiab2

Tennessee District Attorneys Sue Opioid Manufacturers

By John Willis |

Just a few weeks after Ohio’s attorney general filed a landmark lawsuit against the country’s major opioid manufacturers, three Tennessee district attorneys and the mother of a baby born addicted to the powerful painkillers have announced their own litigation. This new lawsuit, filed in Sullivan County, accuses two opioid producers of violating Tennessee’s Drug… Read More »

Facebook Twitter LinkedIn
Segment Pixel